Back
Open Access

SGLT2 Inhibitors as a Central Cardio-Renal-Metabolic Therapy: The Modern Day ACE Inhibitor.

Session: SGLT2 inhibitors and heart failure in the cardiorenal spectrum
Topic: Chronic Heart Failure
Speaker: Doctor M. Vaduganathan (Boston, US)
Organised by CHANGE IME supported by an unrestricted educational grant from AstraZeneca
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Muthiah Vaduganathan

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
16 presentations
4 followers

2 more presentations in this session

Heart failure in context.

Speaker: Professor C. Linde (Stockholm, SE)

Access
Thumbnail

Treating the whole spectrum of heart failure.

Speaker: Professor G. Rosano (London, GB)

Access
Thumbnail

Access the full session

SGLT2 inhibitors and heart failure in the cardiorenal spectrum

Speakers: Doctor M. Vaduganathan, Professor C. Linde, Professor G. Rosano
Access
Video
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb